Brain research bulletin · 2026
Hippocampal ALKBH5 Contributes to Depression-like Behaviors in a Mouse Model of Inflammatory Pain.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Shuwen Deng, Jiayu Zhu, Huamao Zhou, Tang Xiao Han, Weiyi Gong
Аннотация
BACKGROUND: Chronic pain and depressive symptoms frequently coexist and mutually reinforce each other, severely compromising patients' quality of life, yet the underlying central molecular mechanisms remain poorly understood. ALKBH5, an m6A demethylase, has been implicated in the regulation function of central nervous system. However, whether ALKBH5 contributes to depression-like behaviors induced by chronic inflammatory pain remains unknown.
METHODS: The Complete Freund's adjuvant (CFA)-induced inflammatory pain model was employed in this study. ALKBH5 expression and behavioral performances were examined in CFA-treated mice. To further validate the role of hippocampal ALKBH5 in this model, adeno-associated virus (AAV)-mediated shRNA was delivered to knock down ALKB5 in the hippocampus.
RESULTS: ALKBH5 protein levels were significantly unregulated in the hippocampus of CFA mice. Adenovirus-mediated knockdown of hippocampal ALKBH5 markedly alleviated CFA-induced depressive-like behaviors, possibly due to the reduced expression of iNOS.
CONCLUSION: our findings identify hippocampal ALKBH5 as a key regulator of depression-like behaviors in chronic inflammatory pain and suggest that targeting ALKBH5 may provide a novel therapeutic strategy for alleviating affective disorders associated with chronic pain.
METHODS: The Complete Freund's adjuvant (CFA)-induced inflammatory pain model was employed in this study. ALKBH5 expression and behavioral performances were examined in CFA-treated mice. To further validate the role of hippocampal ALKBH5 in this model, adeno-associated virus (AAV)-mediated shRNA was delivered to knock down ALKB5 in the hippocampus.
RESULTS: ALKBH5 protein levels were significantly unregulated in the hippocampus of CFA mice. Adenovirus-mediated knockdown of hippocampal ALKBH5 markedly alleviated CFA-induced depressive-like behaviors, possibly due to the reduced expression of iNOS.
CONCLUSION: our findings identify hippocampal ALKBH5 as a key regulator of depression-like behaviors in chronic inflammatory pain and suggest that targeting ALKBH5 may provide a novel therapeutic strategy for alleviating affective disorders associated with chronic pain.